All the news Showing 10 of 83 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Portal hypertension less likely to fall after HCV treatment when liver stiffness is severe Keith Alcorn / 24 November 2016 Curing hepatitis C infection moderately reduces portal hypertension, but has less impact in people with more severe liver stiffness due to fibrosis, Spanish researchers reported at the 2016 AASLD Liver Meeting last week ... When you eat may contribute to fatty liver disease as much as what you eat Liz Highleyman / 17 November 2016 People who skip breakfast and eat late at night may have an elevated risk of non-alcoholic fatty liver disease (NAFLD), according to research presented this week at the 2016 AASLD Liver Meeting in ... Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment Keith Alcorn / 14 November 2016 People who are cured of hepatitis C after a course of direct-acting antiviral (DAA) treatment do not have a higher risk of developing liver cancer (hepatocellular carcinoma), and probably have a reduced ... Inexpensive interventions can boost engagement with key stages of viral hepatitis care continuum Michael Carter / 14 October 2016 Several cheap interventions can significantly boost engagement with the continuum of care for viral hepatitis, a systematic literature review and a series of meta-analyses published in The Lancet Infectious Diseases show. Programmes led by ... Even low levels of alcohol consumption increase the risk of liver cancer for people with HCV infection with compensated cirrhosis Michael Carter / 05 September 2016 Low-to-moderate alcohol consumption is associated with an increased risk of liver cancer for people with hepatitis C virus (HCV) infection with compensated cirrhosis, investigators from Belgium report in the Journal of Hepatology. Five-year incidence ... Diabetes is a risk factor for the development of liver cancer for people with cirrhosis successfully treated for HCV Michael Carter / 04 July 2016 Diabetes is a strong risk factor for hepatocellular carcinoma (HCC) in people with hepatitis C virus (HCV) infection who have received successful treatment for the infection, Swedish investigators report in Clinical Infectious Diseases. ... Emricasan may improve inflammation and liver function in people with cirrhosis Liz Highleyman / 13 May 2016 The novel caspase inhibitor emricasan led to improvements in various biomarkers and decreases in MELD scores in patients with liver cirrhosis due to hepatitis C, heavy alcohol use or other causes, with significant ... People treated for hepatitis C have unexpectedly high rate of liver cancer recurrence Liz Highleyman / 28 April 2016 Hepatitis C patients with cirrhosis who were treated with direct-acting antivirals had about twice the expected likelihood of developing hepatocellular carcinoma (HCC), with the excess risk seen in people with a previous history ... HCV mortality rates in US increased significantly between 2003 and 2013 Michael Carter / 15 March 2016 There was a significant increase in hepatitis C virus (HCV)-related mortality in the United States between 2003 and 2013, investigators report in the online edition of Clinical Infectious Diseases. Each year, there was ... High cholesterol diet more harmful to the liver for women with hepatitis C than men Keith Alcorn / 17 February 2016 A diet high in cholesterol appears more harmful to the liver, and is more strongly linked to liver-related death and liver transplantation, in women with hepatitis C and advanced fibrosis but not ... ← Prev1...34567...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive